CDC Website CDC Website

To Join the NPIN community or

Home » Improving Hepatitis B and C Care Cascades; Focus on Increased Testing and Diagnosis

Improving Hepatitis B and C Care Cascades; Focus on Increased Testing and Diagnosis

CDC will provide funds to states and limited local Health Departments to work in collaboration with external partners throughout the health care system, and other stakeholders as relevant, to 1) conduct a situational analysis in their jurisdiction to include a) number and description of clinical and other settings that can provide CDC/USPSTF recommended testing and linkages to care and treatment services related to hepatitisC virus (HCV) and hepatitis B virus (HBV) testing and, b) based on this analysis, assess the quality of current HCV and HBV testing and detection activities in each setting; 2) use intervention(s) (with demonstrated success to increase HCV and HBV testing or other preventive health measures) to increase HCV and HBV testing in a population with HBV and/or HCV-related health and healthcare disparities; 3) assess the implementation of selected intervention(s); 4) evaluate the impact of the intervention(s) to increase testing and detection of current infection in sites or organizations serving defined population(s); 5) describe efforts made to link infected patients to care and treatment; and, 6) promote the implementation of successful intervention(s) in similar populations throughout the jurisdiction. The purpose of this FOA is to increase the number of persons living with HBV and/or HCV infection that are tested for these infections and made aware of their infection status to facilitate linkages to recommended care and treatment services To accomplish this goal, awardees are expected to, hire and retain a full-time Viral Hepatitis Coordinator (VHC), or ensure that VHC responsibilities are otherwise assumed and the VHC shall partner with at least one clinical organization or multiple clinical sites (?5 sites) where both testing and linkage to care can be provided (e.g., one organization consisting of ?5 FQHCs or 5 independent FQHCs) or sites/organizations that have an established protocol/agreement to assure persons currently infected HBV and HCV are identified provided follow-up care and services (for example if the setting is corrections, and the partnership is with jails, these jails must demonstrate the ability to link HBV and HCV infected persons to care).

Locations
National
Fund Location Notes
Eligible Organizations
Number of Awards Given
54

Minimum Amount: 

$0.00

Maximum Amount: 

$150,000.00

Average Amount: 

$94,500.00

Award Amount: 

$22,800,000.00
Award Amount Notes
The award ceiling for this FOA is $150,000 per year.  CDC will consider any application requesting an award higher than this amount as non- responsive and it will receive no further review.
Notes
Date for Information Conference Call  June 15, 2016, 11:30am (EDT) to 1:00pm (EDT), Join by phone (404) 553-8912 (Atlanta Dial-in Conference Region)       English (United States) (855) 348-8390 (Atlanta Dial-in Conference Region)       English (United States)   Conference ID: 1000716 Please see complete FOA for more information.
Letter of Intent Date
6/8/16
Application Due Date
8/2/16
Award Date
6/8/16
Open Ended Date
6/8/16
Project Start Date
6/8/16
Application Contact
Gilberto
Ramirez
Project Officer
United States
(404) 718-8535
GHR0@cdc.gov
(404) 718-8535
Technical Contact
Technical Information Management Section
ogstims@cdc.gov
United States
(770) 488-2700
(770) 488-2700
Fund Duration
4 years
Subjects
Audiences
Application Process
Applicants must download the SF-424, Application for Federal Assistance, package associated with the funding opportunity at www.grants.gov. If Internet access is not available, or if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-488-2700 or e-mail at OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access CDC telecommunications at TTY 1-888-232-6348.
Focus Area

Fund Number: 

CDC-RFA-PS17-1702

Fund ID: 

5162

Last Updated: 

6/8/16